BSEBoard Meeting31 Oct 2026 · 31 Oct 2026, 05:12 pm

Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve - Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th September, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. ....

Prism Medico and Pharmacy Ltd · 512217

✦ AI SummaryResults

Prism Medico and Pharmacy Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 to consider and approve the Unaudited Standalone Financial Results for the quarter ended 30th September, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Prism Medico and Pharmacy Ltd - 512217 - Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Attachments (1)

📄

aafe3319-8383-4378-80d9-5d23367d28a2.pdf

pdf

Download →
View document text
PRISM MEDICO AND PHARMACY LIMITED CIN: L24100HP2002PLC009299; Email Id: investorgrievancewmcl@gmail.com Registered Office: Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 Date: 31.10.2026 To. “To, Department of Corporate Services, Listing Department, BSE LIMITED Metropolitan Stock Exchange of India Limited P. J. Towers, Dalal Street, (MSED. Mumbai, Maharashtra-400001. Vibgyor Towers, 4+ Floor, Plot Number C 62, G - Block, Opposite Trident Hotel, Bandra Kurla Complex, , ISIN : INE730E01016 Bandra (E), Mumbai, Maharashtra-400098. Scrip Code: 512217 SYMBOL: PRISMMEDI Subject: Intimation of Board Meeting. Reference: Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as “the Company”) is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Thursday, the 05" day of November, 2026 at 03:30 P.M. inter alia, to: - Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30 September, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. . - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Yours Truly,. FOR PRISM MEDICO AND PHARMACY LIMITED: { DMY yas Yb f- DAVEN DER SINGH INRECTOR DIN: 09447 213.